cardiovascular-disease

Documents about cardiovascular-disease

• Effects of the uremic toxin indoxyl sulphate on human microvascular endothelial cells#424947IRIS
• Bronchiectasis and the risk of cardiovascular disease: A population based study#654955Spiral
• Magnetic Resonance Imaging of the Blood Vessels of the Heart#826750ClinicalTrials.gov
• Genome-wide Epistasis for Cardiovascular Severity in Marfan Study#833439ClinicalTrials.gov
• Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure#840498ClinicalTrials.gov
• Disparities in the Quality of Cardiovascular Care Between HIV‐Infected Versus HIV‐Uninfected Adults in the United States: A Cross‐Sectional Study#491825eScholarship
• Prevalence of Electrocardiographic Changes and Risk Factors for QTc Prolongation Among Steady State Sickle Cell Disease Patients: Cooperative Study of Sickle Cell Disease#449647ODU Digital Commons
• Predictive value of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for in-stent restenosis after drug-eluting stent implantation in patients with coronary heart disease#626367PLOS
• Correlations between the cumulative metabolic score for visceral fat and its dynamic trajectories with the onset of cardiovascular disease in middle-aged and older adults: findings from two prospective cohorts.#9882PubMed
• Mechanism-Driven Therapy for Diabetic Cardiovascular Disease#477034ODU Digital Commons
• Pharmacological blood pressure-lowering for prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual participant data meta-analysis of 46 randomised controlled trials#221885Ora Oxford University Research
• Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health#841564ClinicalTrials.gov
• Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project#6565OpenAlex
• Clustering adipokines, metabolic, oxidative stress, and inflammatory markers associated with cardiovascular disease risk in patients with metabolic syndrome.#9071NCBI PubMed Central
• The Role of Artificial Intelligence in Cardiovascular Disease Risk Prediction: An Updated Review on Current Understanding and Future Research.#25855NCBI PubMed Central
• Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study#28592ClinicalTrials.gov
• Cholesterol management gaps before a recurrent coronary event: insights from the Get With The Guidelines - Coronary Artery Disease registry#68011bioRxiv / medRxiv
• Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)#172444ClinicalTrials.gov
• New Molecular Mechanisms for Cardiovascular Disease:<BR>Contribution of Endothelium-Derived Hyperpolarizing Factor in the Regulation of Vasoconstriction in Peripheral Resistance Arteries#194666J-STAGE (Japan)
• Data for: "Assessing the association between endocrine therapy use in female breast cancer survivors and subsequent risk of cardiovascular disease"#206157LSHTM Data Compass
• Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes#217208ClinicalTrials.gov
• Integrated, Multidisciplinary, Person-centered Care for Patients With Complex Comorbidities: Heart, Kidney and Diabetes#230327ClinicalTrials.gov
• Causal role of EPA on ischemic heart disease, triglyceride rich lipoproteins and related traits: A two-sample Mendelian randomization analysis#234339bioRxiv / medRxiv
• m-Lifestyle Intervention for Employees (m-LIfE): protocol for a pilot cluster randomized controlled trial on cardiovascular disease prevention strategies.#242170NCBI PubMed Central
• Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)#261375ClinicalTrials.gov
• Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention#268120ClinicalTrials.gov
• Editorial: Highlights in Lipids in Cardiovascular Disease: 2021#268571HAL (France)
• Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease.#285166NCBI PubMed Central
• Cardiovascular Comorbidities and Advanced Chronic Kidney Disease in Hospitalized Patients with Multiple Myeloma: A Single-Center Retrospective Cohort Study.#315527NCBI PubMed Central
• How do trait self-control constructs and discounting relate to each other and to modifiable risk factors for cardiovascular disease?#317926NCBI PubMed Central
• Insomnia With Objective Short Sleep Duration Is Associated With Incident Cardiovascular and Cerebrovascular Disease: Evidence from the UK Biobank Data.#326872NCBI PubMed Central
• An enhancer-centric approach applied to human immune system epigenomes revealed the association of macrophage enhancers with cardiovascular disease#339565bioRxiv / medRxiv
• Virtually Delivered Psychosocial Intervention for Mothers Expecting a Baby with Congenital Heart Disease: A Proof-of-Concept Study of HEARTPrep#339595bioRxiv / medRxiv
• Machine learning-based evaluation of lipid biomarkers for cardiovascular risk prediction in chronic kidney disease: A cross-sectional study.#368327NCBI PubMed Central
• The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation#391016ClinicalTrials.gov
• Prescision Medicine in Obstructive Sleep Apnea, Cardiovascular and Cerebrovascular Disease: AI Electrocardiogram Patch Does it All#411270ClinicalTrials.gov
• Genetics of Atherosclerosis in Mexican Americans#442048ClinicalTrials.gov
• Previous schistosome infection and the risk of incident hyperuricemia: A prospective cohort study#443309PLOS
• Sex differences in the gut microbiome and related metabolites: role in cardiometabolic disease.#610600PubMed
• Sedentary Behavior in Older Women With and Without Type 2 Diabetes#806347ClinicalTrials.gov
• Effects of Personality and Context on Recovery From Coronary Artery Bypass#828601ClinicalTrials.gov
• Construction of a Cohort for Pan-Vascular Disease Among Employees of Taizhou People's Hospital#828667ClinicalTrials.gov
• Atherosclerosis, Plaque and CVD in Communities#830070ClinicalTrials.gov
• The Bern Rehab Registry#832672ClinicalTrials.gov
• Impact of Cognitive Behavioral Therapy on PTSD-CVD Link#837794ClinicalTrials.gov
• Framingham Cycle V Offspring-Spouse Nutrition Studies#849640ClinicalTrials.gov
• G.R.I.T. - Goal-directed Resilience Intervention Training#853150ClinicalTrials.gov
• Metabolic risk and metabolic dysfunction–associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study#355242PLOS
• Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease#812999ClinicalTrials.gov
• Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTA#805002ClinicalTrials.gov